E
Xenon Pharmaceuticals Inc. XENE
$37.51 -$0.68-1.78% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 7.50M 7.50M -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue 7.50M 7.50M -- -- --
Cost of Revenue 252.63M 227.34M 210.39M 192.00M 177.91M
Gross Profit -245.13M -219.84M -210.39M -192.00M -177.91M
SG&A Expenses 72.99M 73.15M 68.90M 63.52M 59.62M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 325.62M 300.50M 279.30M 255.52M 237.52M
Operating Income -318.12M -293.00M -279.30M -255.52M -237.52M
Income Before Tax -282.60M -255.52M -238.42M -213.83M -199.34M
Income Tax Expenses -4.37M -4.07M -4.09M -446.00K -283.00K
Earnings from Continuing Operations -278.23 -251.45 -234.33 -213.39 -199.06
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -278.23M -251.45M -234.33M -213.39M -199.06M
EBIT -318.12M -293.00M -279.30M -255.52M -237.52M
EBITDA -315.53M -290.39M -276.77M -252.77M -233.71M
EPS Basic -3.54 -3.22 -3.01 -2.81 -2.74
Normalized Basic EPS -2.25 -2.04 -1.91 -1.76 -1.72
EPS Diluted -3.54 -3.22 -3.01 -2.81 -2.74
Normalized Diluted EPS -2.25 -2.04 -1.91 -1.76 -1.72
Average Basic Shares Outstanding 313.95M 312.67M 311.58M 303.16M 291.24M
Average Diluted Shares Outstanding 313.95M 312.67M 311.58M 303.16M 291.24M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --